However, our subgroup analysis identified that there was no statistical difference of reconstruction rate among breast cancer subtypes in patients with low-grade and early stage tumor, and this finding indirectly confirmed the above-mentioned potential reasons for the relatively lower trends of immediate postmastectomy reconstruction in triple negative or HER2-overexpressing patients. This evidence concerns the gene ERBB2 and breast cancer.